Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasuhiro Yamada

Showing results (321-330 of 351) with videos related to

Pageof 36
Sort By:
Scientific Reports|March 18, 2021
High-dose-rate brachytherapy with external beam radiotherapy versus low-dose-rate brachytherapy with or without external beam radiotherapy for clinically localized prostate cancerHideya Yamazaki, Koji Masui, Gen Suzuki, et al.
Nature Communications|May 27, 2018
In vivo reprogramming drives Kras-induced cancer developmentHirofumi Shibata, Shingo Komura, Yosuke Yamada, et al.
Cell|February 18, 2014
Premature termination of reprogramming in vivo leads to cancer development through altered epigenetic regulationKotaro Ohnishi, Katsunori Semi, Takuya Yamamoto, et al.
Journal of the American Chemical Society|January 28, 2014
Subnanometer vacancy defects introduced on graphene by oxygen gasYasuhiro Yamada, Kazumasa Murota, Ryo Fujita, et al.
Nature Communications|April 20, 2025
PI3K-Akt signalling regulates Scx-lineage tenocytes and Tppp3-lineage paratenon sheath cells in neonatal tendon regenerationAtsushi Goto, Shingo Komura, Koki Kato, et al.
Cell Death and Differentiation|December 18, 2025
Deprivation of EGFR signal causes senolysis in PDAC with CDK4/6 inhibitionYuanyuan Zhang, Susumu Kohno, Keqi Gao, et al.
Hepatology (Baltimore, Md.)|October 24, 2002
Synergistic induction of apoptosis by acyclic retinoid and interferon-beta in human hepatocellular carcinoma cellsAkihiro Obora, Yoshimune Shiratori, Masataka Okuno, et al.
Cell Reports|April 27, 2022
The oncogene-dependent resistance to reprogramming unveils cancer therapeutic targetsKenji Ito, Kohei Nagata, Sho Ohta, et al.
Prostate Cancer|November 4, 2025
MRI-Determined Tumor Contact Area as a Predictor of Pathological Extraprostatic Extension in Clinical T2 Prostate CancerMasashi Tsujimoto, Yuta Inoue, Hideto Taga, et al.
Nature Communications|June 26, 2026
Inherent tissue homeostasis of the juvenile metaphysis provides a foundation for osteosarcoma developmentMasato Saito, Fumie Nakasuka, Nao Sankoda, et al.
Pageof 36

Showing results (321-330 of 351) with videos related to

Sort By:
Pageof 36
Scientific Reports|March 18, 2021
High-dose-rate brachytherapy with external beam radiotherapy versus low-dose-rate brachytherapy with or without external beam radiotherapy for clinically localized prostate cancerHideya Yamazaki, Koji Masui, Gen Suzuki, et al.
Nature Communications|May 27, 2018
In vivo reprogramming drives Kras-induced cancer developmentHirofumi Shibata, Shingo Komura, Yosuke Yamada, et al.
Cell|February 18, 2014
Premature termination of reprogramming in vivo leads to cancer development through altered epigenetic regulationKotaro Ohnishi, Katsunori Semi, Takuya Yamamoto, et al.
Journal of the American Chemical Society|January 28, 2014
Subnanometer vacancy defects introduced on graphene by oxygen gasYasuhiro Yamada, Kazumasa Murota, Ryo Fujita, et al.
Nature Communications|April 20, 2025
PI3K-Akt signalling regulates Scx-lineage tenocytes and Tppp3-lineage paratenon sheath cells in neonatal tendon regenerationAtsushi Goto, Shingo Komura, Koki Kato, et al.
Cell Death and Differentiation|December 18, 2025
Deprivation of EGFR signal causes senolysis in PDAC with CDK4/6 inhibitionYuanyuan Zhang, Susumu Kohno, Keqi Gao, et al.
Hepatology (Baltimore, Md.)|October 24, 2002
Synergistic induction of apoptosis by acyclic retinoid and interferon-beta in human hepatocellular carcinoma cellsAkihiro Obora, Yoshimune Shiratori, Masataka Okuno, et al.
Cell Reports|April 27, 2022
The oncogene-dependent resistance to reprogramming unveils cancer therapeutic targetsKenji Ito, Kohei Nagata, Sho Ohta, et al.
Prostate Cancer|November 4, 2025
MRI-Determined Tumor Contact Area as a Predictor of Pathological Extraprostatic Extension in Clinical T2 Prostate CancerMasashi Tsujimoto, Yuta Inoue, Hideto Taga, et al.
Nature Communications|June 26, 2026
Inherent tissue homeostasis of the juvenile metaphysis provides a foundation for osteosarcoma developmentMasato Saito, Fumie Nakasuka, Nao Sankoda, et al.
Pageof 36